http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019182825-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate | 2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5d1ef80c60b4b41b0addc547675dd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800630af540a446687455dca27d51181 |
publicationDate | 2019-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019182825-A |
titleOfInvention | Ophthalmic composition |
abstract | The present invention provides an ophthalmic composition containing hyaluronic acid or a salt thereof, in which a decrease in viscosity due to storage is sufficiently suppressed. An ophthalmic composition containing (A) hyaluronic acid having a viscosity average molecular weight of 300,000 to 3.9 million and / or a salt thereof, and (B) a water-soluble polymer compound. (B) As a component, at least 1 sort (s) selected from the group which consists of chondroitin sulfate, hydroxypropyl methylcellulose, ethylcellulose, carboxymethylcellulose, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, and these salts is mentioned. [Selection] Figure 1 |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766421-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023054669-A1 |
priorityDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 492.